503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-17.93%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-27.98%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
-14.84%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
3.76%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
-3.41%
R&D reduction while CRWD shows 3.75% growth. Joel Greenblatt would examine competitive risk.
44.77%
G&A growth above 1.5x CRWD's 7.72%. Michael Burry would check for operational inefficiency.
-18.60%
Marketing expense reduction while CRWD shows 1.68% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
-5.71%
Operating expenses reduction while CRWD shows 3.48% growth. Joel Greenblatt would examine advantage.
-13.84%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
5.06%
D&A growth while CRWD reduces D&A. John Neff would investigate differences.
-25.27%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-2.24%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-25.27%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
-8.95%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
-28.90%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
-28.17%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-12.48%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
-26.71%
Both companies reducing tax expense. Martin Whitman would check patterns.
-28.68%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-13.10%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-29.79%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-29.79%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-0.13%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-0.11%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.